Development of donor specific antibodies after SARS-CoV-2 vaccination in kidney and heart transplant recipientsArticle Published on 2022-12-012023-07-10 Journal: Transplant immunology [Category] COVID19(2023년), [키워드] acute rejection COVID-19 infection DSA heart transplant kidney transplant SARS-CoV-2 vaccine. [DOI] 10.1016/j.trim.2022.101722 PMC 바로가기
“COVID toes”: A true viral phenomenon or a diagnosis without a leg to stand on?Review article Published on 2022-12-012022-10-05 Journal: JAAD International [Category] 변종, [키워드] acral lesions acro-ischemia association chilblain-like lesions (CBLL) chilblains coronavirus COVID toes COVID-19 COVID-19 infection cutaneous vasculitis Diagnosis Epstein-Barr virus (EBV) Evidence Factor V Leiden histological Humoral immunity immunological Infection interferon (IFN) lesion lesions lipoprotein A over pandemic Pathogenesis pernio postacute sequelae of COVID-19 (PASC) pseudo-chilblains serological skin of color Support thought Vaccine virus [DOI] 10.1016/j.jdin.2022.06.012 [Article Type] Review article
Kidney Disease and Sars-coV-2 Infection: Challenges and Considerations for NursingReview Published on 2022-12-012023-07-10 Journal: Critical care nursing clinics of North America [Category] COVID19(2023년), [키워드] Acute kidney injury COVID-19 infection Infection Control measures Kidney disease kidney transplant SARS-COV-2 infection Treatment challenges. [DOI] 10.1016/j.cnc.2022.07.007 PMC 바로가기 [Article Type] Review
Impact of COVID-19 pandemic on cancer care: A cross-sectional study of Egyptian patients’ perspectives and concernsResearch article Published on 2022-12-012022-10-05 Journal: Journal of cancer policy [Category] 진단, [키워드] and knowledge beliefs Adjustment Analysis Cancer Cancer care adjustments Care Community Complication conducted COVID-19 COVID-19 and healthcare accessibility COVID-19 infection COVID-19 pandemic cross-sectional Diagnosis Egyptian cancer patients and survivors Follow-up group healthcare healthcare facility Healthcare provision Impact Infection infection control information knowledge less Lower majority media Ministry of Health Modification of cancer treatment occur online survey pandemic Participants Patient Patients’ concerns Patients’ perspectives Perspective Policy probable COVID-19 infection proportion questionnaire reduced remote consultations reported required Resilience Result risk of COVID-19 Safe susceptibility Treatment [DOI] 10.1016/j.jcpo.2022.100359 [Article Type] Research article
Managing ANCA-associated vasculitis during COVID-19 pandemic: a single-center cross-sectional studyArticle Published on 2022-12-012022-11-15 Journal: Rheumatology International [Category] 바이오마커, 진단, [키워드] Active disease ANCA-associated vasculitis Care clinical manifestations Cohort conducted COVID-19 COVID-19 infection COVID-19 severity Critical cross-sectional Cyclophosphamide death demographic died Disease activity Features Follow-up General population Immunosuppressant increased risk India Infection managing moderate non-COVID-19 patient not differ ocular outcome Patient patients patients died predicted receiving regimen required risk of COVID-19 rituximab SARS-CoV-2. severity single-center Supplemental oxygen therapy the patient Treatment Univariate analysis Vasculitis [DOI] 10.1007/s00296-022-05177-2 PMC 바로가기
The Protection of Naturally Acquired Antibodies Against Subsequent SARS-CoV-2 Infection: A Systematic Review and Meta-Analysis후속 SARS-CoV-2 감염에 대한 자연 획득 항체의 보호: 체계적인 검토 및 메타 분석Meta-Analysis Published on 2022-12-012022-09-12 Journal: Emerging Microbes & Infections [Category] COVID19(2023년), SARS, 진단, [키워드] 95% CI Acquired Against analyses analysis antibody asymptomatic infection conducted COVID-19 COVID-19 case COVID-19 infection COVID-19 vaccination Efficacy eligible General population HCWs Health care worker incidence rate individual Infection Meta-analysis Naturally naturally acquired antibody naturally acquired immunity Newcastle-Ottawa Scale NOS Older outcome Population programming protection provided reduce Registration Reinfection reinfection. review risk SARS-CoV-2 SARS-COV-2 infection searched seropositive significant difference significantly specific antibody subsequent symptomatic was used [DOI] 10.1080/22221751.2022.2046446 PMC 바로가기 [Article Type] Meta-Analysis
Evaluation of response to different COVID-19 vaccines in vaccinated healthcare workers in a single center in IranArticle Published on 2022-12-012022-11-15 Journal: Journal of medical virology [Category] COVID19(2023년), SARS, 진단, [키워드] adenoviral-vectored vaccine Administered administration age anti-SARS-CoV-2 Anti-spike anti-spike antibody antibody Antibody Response average blood sample calculated center coronavirus disease Covaxin COVID-19 COVID-19 infection COVID-19 vaccine Cutoff ELISA evaluated Frequency healthcare worker individual Iran men Neutralizing antibodies neutralizing antibody neutralizing antibody. outcome Oxford/AstraZeneca pandemic participant participated positive proportion second dose significantly higher single center Sinopharm Sputnik V vaccination Vaccine Vaccines [DOI] 10.1002/jmv.28029 PMC 바로가기
Severity of SARS-CoV-2 Omicron BA.2 infection in unvaccinated hospitalized children: comparison to influenza and parainfluenza infections예방접종을 받지 않은 입원 소아에서 SARS-CoV-2 Omicron BA.2 감염의 심각도: 인플루엔자 및 파라인플루엔자 감염과의 비교Article Published on 2022-12-012022-09-11 Journal: Emerging Microbes & Infections [Category] COVID19(2023년), SARS, 변종, [키워드] 95%CI acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 adjusted Admission children Clinical outcome coronavirus COVID-19 COVID-19 infection Croup database death had no hospitalisation hospitalisations Hospitalization Hospitalized Infection Influenza Influenza virus initial investigated Mild neurological Neurological complication Neurological complications occurred omicron outcome parainfluenza parainfluenza virus proportion Public Hospital Relative risk required respiratory. retrieved risk SARS-CoV-2 severe acute respiratory syndrome Coronavirus severity uninfected upper airway upper airways vaccination variant viral infections virus viruses were recorded [DOI] 10.1080/22221751.2022.2093135 PMC 바로가기 [Article Type] Article
Antibody response to SARS-CoV-2 vaccines among hospitalized patients in China: a case-control studyArticle Published on 2022-11-302022-11-15 Journal: Human vaccines & immunotherapeutics [Category] COVID19(2023년), SARS, 진단, [키워드] age anti-SARS-CoV-2 antibodies antibody Antibody Response Case-control case-control study China confidence interval Control COVID-19 infection COVID-19 pandemic Department dose Hospitalization hospitalization. hospitalized patient inactivated lack management Odds ratio participant Participants Protective SARS-CoV-2 SARS-CoV-2 vaccination SARS-CoV-2 vaccine seroconversion rate seronegative seronegative participant seropositive participant Sex Sinopharm tested the antibody response the SARS-CoV-2 the vaccine Urology vaccination Vaccine was obtained were assessed [DOI] 10.1080/21645515.2022.2088966 PMC 바로가기
Breakthrough SARS-CoV-2 infections after vaccination: a critical review백신 접종 후 획기적인 SARS-CoV-2 감염: 비판적 검토Review Published on 2022-11-302022-09-12 Journal: Human vaccines & immunotherapeutics [Category] MERS, SARS, 진단, [키워드] acute respiratory syndrome antibody assumption breakthrough coronavirus COVID-19 COVID-19 infection Critical Evidence Humoral immunity Immunity immunization individual induce infected patients Infection pandemic raised Reinfection SARS-CoV-2 SARS-COV-2 infection unlikely vaccination vaccination. [DOI] 10.1080/21645515.2022.2051412 PMC 바로가기 [Article Type] Review